NL-OMON53975
Recruiting
Not Applicable
Measuring blood-brain barrier integrity non-invasively with MRI - COGA BBB-MRI
Amsterdam UMC0 sites0 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Amsterdam UMC
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion criteria of the COGA study includes all patients who consent to their
- •data being released for scientific research, by signing the informed consent
- •for the general protocol (METC 2017\.148\)
Exclusion Criteria
- •Contraindications for MRI, such as claustrophobia or the presence of metal in
Outcomes
Primary Outcomes
Not specified
Similar Trials
Withdrawn
Not Applicable
Evaluation of Blood Brain Barrier Integrity and Relationship to Structural Brain Abnormalities in MPS IIIB Patients Using Cerebrospinal Fluid/Serum Albumin Index (CSF-AI) and Multimodal Magnetic Resonance ImagingSanfilippo BSanfilippo disease10021605NL-OMON38912Synegeva6
Completed
Not Applicable
Blood-Brain Barrier permeability quantification in cerebral small vessel disease -- reproducibility of dynamic contrast-enhanced MRICerebral small vessel diseasedisease of the small brain arteries10007963NL-OMON38519Medisch Universitair Ziekenhuis Maastricht20
Recruiting
Not Applicable
Quantitative blood-brain barrier permeability and susceptibility mapping for patients with CADASIL and suspected to have CADASICADASIJPRN-UMIN000035081agoya City University40
Completed
Not Applicable
Evaluation of Blood Brain Barrier Integrity and Structural Abnormalities in MPS IIIB Patients Using Multimodal Magnetic Resonance ImagingMPS IIIB (Sanfilippo B Syndrome)NCT02090179Alexion Pharmaceuticals, Inc.5
Not yet recruiting
Not Applicable
Quantitative MRI for Blood Brain Barrier integrity Assessment without Gadolinium Based Contrast AgentsNL-OMON56940Erasmus MC, Universitair Medisch Centrum Rotterdam230